How would you treat a stage IIA NS HD patient with bulky disease who refuses chemotherapy?
What field design and dosing is most appropriate? Would you use ISRT or a more extended field?
Answer from: Radiation Oncologist at Academic Institution
If this patient presented 25-30 years ago, there would have been very little debate on how to proceed. The patient would have been treated with subtotal nodal irradiation. This would have consisted of a mantle field, treating all major lymph node-bearing areas above the diaphragm, typically to a dos...
Sign in or Register to read more